Navigation Links
Ocuvite® PreserVision® Tablets AREDS formula

ProductsOcuvite® PreserVision® Tablets AREDS formula
Company Bausch & Lomb, Inc.
Item Ocuvite® PreserVision® Tablets AREDS formula
Features 
  • Clinically proven effective
  • Follow the regimen used in the study; 4 pills daily - 2 in the morning, 2 in the evening every day with meals.
  • The PreserVision® Brand is also available in an easy to swallow, 2-per-day soft gels format.
Description PreserVision® AREDS formula is the one and only vitamin and mineral formula proven effective in the National Eye Institute's age-related eye study (AREDS) 10-year trial. 4 tablets per day format.

The 10-year clinical Age-Related Eye Disease Study (AREDS) by the National Eye Institute (a division of the National Institutes of Health) showed that a unique vitamin and mineral supplement may help slow the progression of age-related macular degeneration and its associated vision loss among patients most at risk.

Info Bausch & Lomb, Inc.
Customer Service: 585-338-6000
Web site: http://www.bausch.com/en_US/

Related medicine products :

1. Ocuvite® Adult and Ocuvite® Adult 50+ age-adjusted formulas
2. Ocuvite® Lutein Eye Vitamin and Mineral Supplements
3. Ocuvite® Extra Eye Vitamin and Mineral Supplements
4. Ocuvite® Eye Vitamins and Mineral Supplement
5. PreserVision® Soft Gels AREDS Eye Vitamins
6. PreserVision® Soft Gels Lutein Eye Vitamins
... The Company has developed the patented HydroKeratome ... LASIK procedure. Management and industry experts believe ... instrument, or microkeratome, currently used in the ... eye studies, the Company has demonstrated that ...
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
3.5v Ophthalmic Diagnostic Set with Diagnostic Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: